- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 976926, 10 pages
Hochuekkito (TJ-41), a Kampo Formula, Ameliorates Cachexia Induced by Colon 26 Adenocarcinoma in Mice
1Department of Respiratory Medicine, School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
2Research Institute for Diseases of Old Age, School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
3Center for Advanced Kampo Medicine and Clinical Research, School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
4Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku-ku, Tokyo 160-8582, Japan
Received 26 September 2012; Revised 2 December 2012; Accepted 2 December 2012
Academic Editor: Angelo Antonio Izzo
Copyright © 2012 Suzu Yae et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. N. Gordon, S. R. Green, and P. M. Goggin, “Cancer cachexia,” Quarterly Journal of Medicine, vol. 98, no. 11, pp. 779–788, 2005.
- M. J. Tisdale, “Cachexia in cancer patients,” Nature Reviews Cancer, vol. 2, no. 11, pp. 862–871, 2002.
- M. Muscaritoli, M. Bossola, Z. Aversa, R. Bellantone, and F. Rossi Fanelli, “Prevention and treatment of cancer cachexia: new insights into an old problem,” European Journal of Cancer, vol. 42, no. 1, pp. 31–41, 2006.
- M. J. Tisdale, “Mechanisms of cancer cachexia,” Physiological Reviews, vol. 89, no. 2, pp. 381–410, 2009.
- M. J. Tisdale, “Pathogenesis of cancer cachexia,” The Journal of Supportive Oncology, vol. 1, no. 3, pp. 159–168, 2003.
- M. J. Tisdale, “Biology of cachexia,” Journal of the National Cancer Institute, vol. 89, no. 23, pp. 1763–1773, 1997.
- D. S. Hong, L. S. Angelo, and R. Kurzrock, “Interleukin-6 and its receptor in cancer: implications for translational therapeutics,” Cancer, vol. 110, no. 9, pp. 1911–1928, 2007.
- G. Strassmann, M. Fong, J. S. Kenney, and C. O. Jacob, “Evidence for the involvement of interleukin 6 in experimental cancer cachexia,” Journal of Clinical Investigation, vol. 89, no. 5, pp. 1681–1684, 1992.
- G. Strassmann and T. Kambayashi, “Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine-receptor therapy,” Cytokines and Molecular Therapy, vol. 1, no. 2, pp. 107–113, 1995.
- K. Ando, F. Takahashi, S. Motojima, et al., “Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia,” Journal of Clinical Oncology. In press.
- A. Kuroiwa, S. Liou, H. Yan, A. Eshita, S. Naitoh, and A. Nagayama, “Effect of a traditional Japanese herbal medicine, Hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly persons,” International Immunopharmacology, vol. 4, no. 2, pp. 317–324, 2004.
- N. Satoh, S. Sakai, T. Kogure et al., “A randomized double blind placebo-controlled clinical trial of Hochuekkito, a traditional herbal medicine, in the treatment of elderly patients with weakness N of one and responder restricted design,” Phytomedicine, vol. 12, no. 8, pp. 549–554, 2005.
- K. Tatsumi, N. Shinozuka, K. Nakayama, N. Sekiya, T. Kuriyama, and Y. Fukuchi, “Hochuekkito improves systemic inflammation and nutritional status in elderly patients with chronic obstructive pulmonary disease,” Journal of the American Geriatrics Society, vol. 57, no. 1, pp. 169–170, 2009.
- K. Fujimoto-Ouchi, S. Tamura, K. Mori, Y. Tanaka, and H. Ishitsuka, “Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma,” International Journal of Cancer, vol. 61, no. 4, pp. 522–528, 1995.
- S. Tajima, M. Bando, H. Yamasawa et al., “Preventive effect of Hochu-ekki-to on lipopolysaccharide-induced acute lung injury in BALB/c mice,” Lung, vol. 184, no. 6, pp. 318–323, 2006.
- S. Tajima, M. Bando, H. Yamasawa et al., “Preventive effect of hochu-ekki-to, a Japanese herbal medicine, on bleomycin-induced lung injury in mice,” Respirology, vol. 12, no. 6, pp. 814–822, 2007.
- Y. Zhang, S. Wang, Y. Li, Z. Xiao, Z. Hu, and J. Zhang, “Sophocarpine and matrine inhibit the production of TNF- and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice,” International Immunopharmacology, vol. 8, no. 13-14, pp. 1767–1772, 2008.
- J. Fujita, T. Tsujinaka, M. Yano, et al., “Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways,” International Journal of Cancer, vol. 68, pp. 637–643, 1996.
- Y. Tanaka, H. Eda, T. Tanaka et al., “Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice,” Cancer Research, vol. 50, no. 8, pp. 2290–2295, 1990.
- T. Matsumoto, M. Moriya, H. Kiyohara, Y. Tabuchi, and H. Yamada, “Hochuekkito, a Kampo (Traditional Japanese Herbal) medicine, and its polysaccharide portion stimulate G-CSF secretion from intestinal epithelial cells,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 3, pp. 331–340, 2010.
- K. Minakata, F. Takahashi, T. Nara, et al., “Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors,” Cancer Science, vol. 103, no. 11, pp. 1946–1954, 2012.
- Y. Uezono, K. Miyano, M. Suzuki, et al., “A review of traditional Japanese medicines and their potential mechanism of action,” Current Pharmaceutical Design, vol. 18, no. 31, pp. 4839–4853, 2012.
- M. Yamaya, T. Sasaki, H. Yasuda et al., “Hochu-ekki-to inhibits rhinovirus infection in human tracheal epithelial cells,” British Journal of Pharmacology, vol. 150, no. 6, pp. 702–710, 2007.
- B. Seruga, H. Zhang, L. J. Bernstein, and I. F. Tannock, “Cytokines and their relationship to the symptoms and outcome of cancer,” Nature Reviews Cancer, vol. 8, no. 11, pp. 887–899, 2008.
- K. G. Billingsley, D. L. Fraker, G. Strassmann, C. Loeser, H. M. Fliot, and H. R. Alexander, “Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: possible cellular mechanisms of cancer cachexia,” Annals of Surgical Oncology, vol. 3, no. 1, pp. 29–35, 1996.
- P. Arner, “Lipases in cachexia,” Science, vol. 333, no. 6039, pp. 163–164, 2011.
- S. K. Das, S. Eder, S. Schauer et al., “Adipose triglyceride lipase contributes to cancer-associated cachexia,” Science, vol. 333, no. 6039, pp. 233–238, 2011.
- K. Soda, M. Kawakami, A. Kashii, and M. Miyata, “Characterization of mice bearing subclones of colon 26 adenocarcinoma disqualifies interleukin-6 as the sole inducer of cachexia,” Japanese Journal of Cancer Research, vol. 85, no. 11, pp. 1124–1130, 1994.
- Y. Naoe, I. Kawamura, M. Inami et al., “Anti-cachectic effect of FK317, a novel anti-cancer agent, in Colon26 and LX-1 models in mice,” Japanese Journal of Cancer Research, vol. 89, no. 12, pp. 1318–1325, 1998.
- K. Kuroda, Y. Horiguchi, J. Nakashima et al., “Prevention of cancer cachexia by a novel nuclear factor B inhibitor in prostate cancer,” Clinical Cancer Research, vol. 11, no. 15, pp. 5590–5594, 2005.